ADHD Medications May Reduce Risks of Addiction, Suicide, Accidents, and Crime, Study Finds

Medication for attention deficit hyperactivity disorder (ADHD) may do more than manage core symptoms,according to BBC News.It could also lower the risk of serious life challenges, including substance misuse, suicidal behaviour, transport accidents, and criminality, according to new research.

The study, published in the British Medical Journal (BMJ), analysed health records of 148,500 people aged 6–64 in Sweden diagnosed with ADHD. Around 57% began drug treatment, and of these, 88% were prescribed methylphenidate (Ritalin).

Researchers from the University of Southampton and the Karolinska Institute found significant reductions in first-time incidents among those on medication:

When recurrent events were included, ADHD drugs were linked to even greater reductions — 25% for substance misuse and criminal behaviour, 15% for suicide attempts, 16% for transport accidents, and 4% for accidental injuries.

Prof. Samuele Cortese, study author and professor of child and adolescent psychiatry at the University of Southampton, said these findings address an important gap: “Oftentimes there is no information on what the risks are if you don’t treat ADHD. Now we have evidence they can reduce these risks.”

The benefits may stem from reduced impulsivity and improved concentration, potentially lowering accident risks and aggressive behaviours. However, the researchers note that factors such as genetics, lifestyle, and ADHD severity could also influence the results.

ADHD affects an estimated 5% of children and 2.5% of adults globally. While diagnoses are increasing, experts say prevalence is not rising — instead, more people are seeking help. Symptoms must cause at least moderate life impact to qualify for diagnosis.

Stimulant medications are the most common treatment and help manage day-to-day challenges, though concerns remain about side effects such as headaches, appetite loss, and sleep problems. Long waiting times and medication shortages in countries like the UK further limit access, sometimes delaying treatment for years.

Prof. Stuart Kinner of Curtin University described the findings as evidence of “the diffuse benefits of ADHD diagnosis and treatment,” warning that untreated ADHD can lead to self-medication, poor mental health, and incarceration.

Ian Maidment, professor of clinical pharmacy at Aston University, welcomed the study but noted it did not assess whether patients adhered to their prescriptions or the effects of different doses.